ZA9610458B - Novel method. - Google Patents
Novel method.Info
- Publication number
- ZA9610458B ZA9610458B ZA9610458A ZA9610458A ZA9610458B ZA 9610458 B ZA9610458 B ZA 9610458B ZA 9610458 A ZA9610458 A ZA 9610458A ZA 9610458 A ZA9610458 A ZA 9610458A ZA 9610458 B ZA9610458 B ZA 9610458B
- Authority
- ZA
- South Africa
- Prior art keywords
- novel method
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9525481.9A GB9525481D0 (en) | 1995-12-13 | 1995-12-13 | Novel method |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA9610458B true ZA9610458B (en) | 1998-06-12 |
Family
ID=10785365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9610458A ZA9610458B (en) | 1995-12-13 | 1996-12-12 | Novel method. |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU1376297A (en) |
GB (1) | GB9525481D0 (en) |
WO (1) | WO1997021833A1 (en) |
ZA (1) | ZA9610458B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6280763B1 (en) | 1999-05-10 | 2001-08-28 | Pierce Management, Llc | Apparatus and method for transdermal delivery of bupropion |
EP2570495B1 (en) * | 2008-01-02 | 2015-09-09 | SureGene LLC | Genetic markers of mental illness |
CA2712075A1 (en) * | 2008-01-17 | 2009-07-23 | Suregene Llc | Genetic markers of mental illness |
GB2524519B (en) * | 2014-03-25 | 2019-11-06 | Pelago Bioscience AB | Methods for identifying a biomarker indicative of a reduced drug response using a thermal shift assay |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2718329B1 (en) * | 1994-03-21 | 2002-09-20 | Rhone Poulenc Rorer Sa | Transgenic rabbit sensitized to dyslipoproteinemias. |
GB9408465D0 (en) * | 1994-04-27 | 1994-06-22 | Univ Mcgill | Apolipoprotein e polymorphism & treatment of alzheimer's disease |
-
1995
- 1995-12-13 GB GBGB9525481.9A patent/GB9525481D0/en active Pending
-
1996
- 1996-12-11 AU AU13762/97A patent/AU1376297A/en not_active Abandoned
- 1996-12-11 WO PCT/EP1996/005734 patent/WO1997021833A1/en active Application Filing
- 1996-12-12 ZA ZA9610458A patent/ZA9610458B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU1376297A (en) | 1997-07-03 |
WO1997021833A1 (en) | 1997-06-19 |
GB9525481D0 (en) | 1996-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA967315B (en) | Biphenylamides. | |
MX213417B (en) | Phenylpyridazinones. | |
ZA964468B (en) | Triazolylmethyl-cyclopentanols. | |
ZA961955B (en) | Indazolecarboxamides. | |
DE69610844D1 (en) | Hydroformylierungsverfahren. | |
GB9518442D0 (en) | Method | |
GB9519638D0 (en) | Method | |
GB2308522B (en) | Redialling method | |
ZA966399B (en) | Endothelin-receptor-antagonists. | |
GB9502225D0 (en) | Method | |
ZA9610458B (en) | Novel method. | |
ZA966933B (en) | Endothelin-receptor-antagonists. | |
ZA966750B (en) | Halogenobenzimidazoles. | |
GB9510727D0 (en) | Method | |
ZA962716B (en) | Novel method | |
ZA967314B (en) | Carbamoylcarboxamides. | |
ZA971775B (en) | Novel method. | |
GB9511828D0 (en) | Method | |
ZA969560B (en) | Substituted 1-methyl-3-phenylpyrazoles. | |
ZA966379B (en) | Novel process. | |
GR2001758Y (en) | Quick adding method. | |
ZA972384B (en) | Production method. | |
PL324509A1 (en) | Novel method | |
GB9526330D0 (en) | Novel method | |
ZA969780B (en) | Cyclopeptolides. |